Trump Approves $35 Billion Medicare Expansion for Weight-Loss Drugs, Critics Call it 'Welfare for Big Pharma'

Medicare Expansion for Weight-Loss Drugs

• 🎯 Donald Trump has approved a $35 billion Medicare expansion to cover weight-loss drugs like Ozempic and Wegovy.
• 💰 This move is criticized as a "welfare giveaway" to Big Pharma, specifically benefiting companies like Novo Nordisk and Eli Lilly.
• ⚠️ Concerns are raised about the potential for these drugs to cause serious side effects, including blindness and stomach paralysis, and that they were originally intended for serious diabetes treatment.

Financial and Political Implications

• 💸 The expansion is projected to add $35 billion annually to the national debt, contradicting promises of fiscal responsibility.
• 🤝 Critics point to the influence of corporate money in politics, noting that many members of Congress have received funding from drug manufacturers like Novo Nordisk.
• 📉 The decision is contrasted with alternative uses for the funds, such as purchasing regeneratively raised organic food and gym memberships for obese Americans, which would cost significantly less.

Criticisms and Comparisons

• 📢 Robert F. Kennedy Jr. is cited for his remarks on the "Ozempic scam," highlighting that if a drug is approved for Medicare, it automatically extends to Medicaid, covering a broader population.
• 📺 The move is compared to previous "giveaways" to Big Pharma and health insurance companies, such as during the Obama administration with Obamacare and Trump's Operation Warp Speed.
• 🏥 While Medicare was previously prohibited from covering weight-loss medications, recent FDA approvals for drugs treating heart conditions have opened doors, though coverage for obesity alone has lagged.

Trump's Stance and Public Reaction

• 🤔 Trump refers to the drugs as "fat pills" or "fat drugs" and claims to have heard only good things about them, despite reports of negative side effects.
• 🤷 The speaker expresses disbelief that Trump is unaware of the reported side effects, which have already been discussed on shows like The Jimmy Dore Show.
• 📉 The decision is seen as bailing out billionaires and Big Pharma, while simultaneously cutting other social programs and increasing the national debt.